Innovation Pharmaceuticals is presenting a scientific poster on the planned continued development of Brilacidin for Inflammatory Bowel Disease at the inaugural “IBD Innovate 2018” conference.

The scientific poster—titled “Brilacidin for Inflammatory Bowel Disease: A Novel, Non-Corticosteroid, Non-Biologic Drug Candidate in Clinical Development”—is available here (pdf).

Conference participants include diverse stakeholders interested in scientific advances and innovative programs toward accelerating the introduction of novel products to address unmet medical needs in the treatment of chronic bowel diseases.

Additional conference details can be found on the Crohn’s & Colitis Foundation website by clicking here (pdf of full agenda).